全文获取类型
收费全文 | 7858篇 |
免费 | 322篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 72篇 |
儿科学 | 142篇 |
妇产科学 | 111篇 |
基础医学 | 1361篇 |
口腔科学 | 108篇 |
临床医学 | 707篇 |
内科学 | 1914篇 |
皮肤病学 | 94篇 |
神经病学 | 714篇 |
特种医学 | 225篇 |
外科学 | 1005篇 |
综合类 | 55篇 |
一般理论 | 3篇 |
预防医学 | 452篇 |
眼科学 | 45篇 |
药学 | 577篇 |
中国医学 | 8篇 |
肿瘤学 | 631篇 |
出版年
2023年 | 15篇 |
2022年 | 29篇 |
2021年 | 81篇 |
2020年 | 41篇 |
2019年 | 69篇 |
2018年 | 82篇 |
2017年 | 53篇 |
2016年 | 66篇 |
2015年 | 115篇 |
2014年 | 156篇 |
2013年 | 229篇 |
2012年 | 479篇 |
2011年 | 494篇 |
2010年 | 257篇 |
2009年 | 269篇 |
2008年 | 487篇 |
2007年 | 547篇 |
2006年 | 591篇 |
2005年 | 655篇 |
2004年 | 599篇 |
2003年 | 628篇 |
2002年 | 550篇 |
2001年 | 103篇 |
2000年 | 79篇 |
1999年 | 114篇 |
1998年 | 159篇 |
1997年 | 126篇 |
1996年 | 105篇 |
1995年 | 93篇 |
1994年 | 112篇 |
1993年 | 84篇 |
1992年 | 69篇 |
1991年 | 49篇 |
1990年 | 64篇 |
1989年 | 40篇 |
1988年 | 55篇 |
1987年 | 57篇 |
1986年 | 39篇 |
1985年 | 51篇 |
1984年 | 35篇 |
1983年 | 32篇 |
1982年 | 40篇 |
1981年 | 45篇 |
1980年 | 31篇 |
1979年 | 19篇 |
1978年 | 29篇 |
1977年 | 19篇 |
1975年 | 10篇 |
1974年 | 14篇 |
1973年 | 19篇 |
排序方式: 共有8224条查询结果,搜索用时 15 毫秒
61.
Vermeesch JR Melotte C Salden I Riegel M Trifnov V Polityko A Rumyantseva N Naumchik I Starke H Matthijs G Schinzel A Fryns JP Liehr T 《European journal of medical genetics》2005,48(3):319-327
A dysmorphic patient was shown to carry a small supernumerary marker chromosome. Multicolor, centromere-multicolor and regular FISH experiments proved the marker to be an analphoid 12pter derived isochromosome. Microdissection of the marker followed by reverse painting and array CGH analysis showed that the isochromosome contains approximately 6 Mb of 12pter-12p13.31 derived sequence. This is only the second report of a marker with a neocentromere 12pter and the molecular fine mapping of the duplicated region further refines the 12p region defining the Pallister-Killian syndrome phenotype. In addition, we show the feasibility of using microdissected chromosomes or chromosomal fragments to molecularly map the chromosomal breakpoints on array CGH. This technology may aid in the identification of chromosomal translocation breakpoints. 相似文献
62.
63.
Schrander-Stumpel CT Curfs LM Sastrowijoto P Cassidy SB Schrander JJ Fryns JP 《American journal of medical genetics. Part A》2004,(4):333-338
The peroxisome biogenesis disorders (PBDs) with generalized peroxisomal dysfunction include Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD). There is clinical, biochemical, and genetic overlap among the three phenotypes, also known as Zellweger spectrum disorders. Clinical distinctions between the phenotypes are not sharply defined. Only limited sources are available to serve as a background for prognosis in PBD, especially in case of prolonged survival. We delineated the natural history of 31 PBD patients (age 1.2-24 years) through systematic clinical and biochemical investigations. We excluded classical ZS from our study, and included all patients with a biochemically confirmed generalized peroxisomal disorder over 1 year of age, irrespective of the previously diagnosed phenotype. The initial clinical suspicion, age at diagnosis, growth, development, neurological symptoms, organ involvements, and survival are summarized. Common to all patients were cognitive and motor dysfunction, retinopathy, sensorineural hearing impairment, and hepatic involvement. Many patients showed postnatal growth failure, 10 patients displayed hyperoxaluria of whom 4 had renal stones. Motor skills ranged from sitting with support to normal gait. Speech development ranged from non-verbal expression to grammatical speech and comprehensive reading. The neurodevelopmental course was variable with stable course, rapid decline with leukodystrophy, spinocerebellar syndrome, and slow decline over a wide range of faculties as outcome profiles. At the molecular level, 21 patients had mutations in the PEX1 gene. The two most common PEX1 mutations were the G843D (c.2528G-->A) missense and the c.2097insT frameshift mutation. Patients having the G843D/G843D or the G843D/c.2097insT genotypes were compared. Patients homozygous for G843D generally had a better developmental outcome. However, one patient who was homozygous for the "mild" G843D mutation had an early lethal disease, whereas two other patients had a phenotype overlapping with the G843D/c.2097insT group. This indicates that next to the PEX1 genotype other yet unknown factors determine the ultimate phenotype. 相似文献
64.
65.
66.
MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma 总被引:3,自引:0,他引:3
Leroy X Zerimech F Zini L Copin MC Buisine MP Gosselin B Aubert JP Porchet N 《American journal of clinical pathology》2002,118(1):47-51
We studied, by immunohistochemical analysis, the expression of MUC1 and epithelial membrane antigen in 44 stage pT1 renal cell carcinomas (RCCs). Six patients had a metastatic evolution. The percentage of stained cells was determined for each tumor. All tumors and normal adjacent renal parenchyma were stained. In normal kidney, distal convoluted tubules and collecting ducts stained strongly with an apical distribution. In tumors, there was a significant statistical correlation of the MUC1 expression level with the nuclear grade and with tumor progression. High-grade tumors had more stained cells than did low-grade tumors. Metastatic tumors also were more stained than nonmetastatic lesions. By using the Kaplan-Meier method and the log-rank test, we observed that patients with fewer than 10% of stained cells had no metastatic evolution. In contrast, patients with 70% or more stained cells had significantly lower metastasis-free survival rates. We conclude that MUC1 is expressed in RCC and is associated with tumor progression in pT1 RCC. 相似文献
67.
68.
69.
Descamps D Flandre P Joly V Meiffrédy V Peytavin G Izopet J Tamalet C Zeng AF Harel M Lastère S Aboulker JP Yéni P Brun-Vézinet F;NOVAVIR 《Journal of acquired immune deficiency syndromes (1999)》2002,31(5):464-471
The authors studied the effect of zidovudine (ZDV) resistance mutation on virologic response to treatment with ZDV or stavudine (d4T) each in combination with lamivudine and indinavir. Viral genotyping was performed on plasma HIV-1 RNA at study entry and concerned 155 patients previously treated with ZDV, didanosine, or zalcitabine and enrolled in the NOVAVIR (Agence National de Recherche sur le SIDA [ANRS] 073) trial. Three virologic responses were investigated: early response (<50 copies/mL at week 24), late response (<500 copies/mL at week 80), and virologic failure (two HIV-1 RNA >5000 copies/mL). Patients were classified as resistant or susceptible to ZDV according to the ANRS algorithm. Plasma viral RNA from 123 of 155 patients had two or more ZDV resistance mutations. The number of ZDV resistance mutations was positively correlated with the duration of prior antiviral therapy (p <.001). At week 24, 74% and 77% of patients with virus classified as resistant were responders in the d4T and ZDV arm, respectively. Similar results were found at week 80. Virologic failure was reached in 7 of 24 patients with virus classified as susceptible and in 26 of 131 patients with resistant virus (p =.29). In the ZDV arm, patients classified as resistant had longer times to virologic failure than those classified as susceptible (p =.003). In conclusion, sustained virologic response despite presence of ZDV resistance mutations implies that these mutations do not preclude an early and durable response to treatment with a potent three-drug regimen in these patients. Patients susceptible to ZDV had lower median mean corpuscular volumes and lower random indinavir levels, suggesting that adherence was the main reason for failure. 相似文献
70.
Frints SG Jun L Fryns JP Devriendt K Teulingkx R Van den Berghe L De Vos B Borghgraef M Chelly J Des Portes V Van Bokhoven H Hamel B Ropers HH Kalscheuer V Raynaud M Moraine C Marynen P Froyen G 《American journal of medical genetics. Part A》2003,(3):367-374
We describe a 59-year-old male (patient A059) with moderate to severe mental retardation (MR) and a pericentric inversion of the X-chromosome: inv(X)(p21.1;q22.1). He had short stature, pectus excavatum, general muscle wasting, and facial dysmorphism. Until now, no other patients with similar clinical features have been described in the literature. Molecular analysis of both breakpoints led to the identification of a novel "Nuclear RNA export factor" (NXF) gene cluster on Xq22.1. Within this cluster, the NXF5 gene was interrupted with subsequent loss of gene expression. Hence, mutation analysis of the NXF5 and its neighboring homologue, the NXF2 gene was performed in 45 men with various forms of syndromic X-linked MR (XLMR) and in 70 patients with nonspecific XLMR. In the NXF5 gene four nucleotide changes: one intronic, two silent, and one missense (K23E), were identified. In the NXF2 gene two changes (one intronic and one silent) were found. Although none of these changes were causative mutations, we propose that NXF5 is a good candidate gene for this syndromic form of XLMR, given the suspected role of NXF proteins is within mRNA export/transport in neurons. Therefore, mutation screening of the NXF gene family in phenotypically identical patients is recommended. 相似文献